The Latest in Hematology Times

EC approves CAR T-cell therapy for DLBCL, PMBCL

August 28, 2018

EC approves product for high-risk AML

August 28, 2018

FDA grants fast track designation to CX-01 for AML

August 28, 2018

EC approves CAR T-cell therapy for ALL, DLBCL

August 27, 2018

FDA approves new use for ibrutinib in WM

August 27, 2018

Rivaroxaban doesn’t reduce risk of fatal VTE

August 27, 2018

Thrombosis

Regimen appears effective in elderly, unfit MDS/AML

August 25, 2018

Study reveals ‘complete mental health’ among cancer survivors

August 24, 2018

Combo produces high response rate in CLL

August 24, 2018

Drug receives priority review for second MM indication

August 24, 2018

Multiple Myeloma

D-dimer and WCP can render VDUs unnecessary

August 23, 2018

Thrombosis

Enzymes convert blood from type A to O more efficiently

August 23, 2018

Blood Banking

AMP publishes report on DNA variants in CMNs

August 23, 2018

Signal strength tied to potency of CAR T-cell therapy

August 22, 2018

FDA grants priority review to drug for PNH

August 22, 2018